Your browser doesn't support javascript.
loading
A phase I trial of paclitaxel, cisplatin, and veliparib in the treatment of persistent or recurrent carcinoma of the cervix: an NRG Oncology Study (NCT#01281852).
Thaker, P H; Salani, R; Brady, W E; Lankes, H A; Cohn, D E; Mutch, D G; Mannel, R S; Bell-McGuinn, K M; Di Silvestro, P A; Jelovac, D; Carter, J S; Duan, W; Resnick, K E; Dizon, D S; Aghajanian, C; Fracasso, P M.
Afiliação
  • Thaker PH; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Siteman Cancer Center, Washington University School of Medicine, St. Louis.
  • Salani R; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, The Ohio State University School of Medicine, Columbus, USA.
  • Brady WE; NRG/Gynecologic Oncology Group Statistical and Data Center, Roswell Park Cancer Institute, Buffalo, USA.
  • Lankes HA; NRG/Gynecologic Oncology Group Statistical and Data Center, Roswell Park Cancer Institute, Buffalo, USA.
  • Cohn DE; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, The Ohio State University School of Medicine, Columbus, USA.
  • Mutch DG; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Siteman Cancer Center, Washington University School of Medicine, St. Louis.
  • Mannel RS; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Oklahoma, Oklahoma City, USA.
  • Bell-McGuinn KM; Department of Medicine, Gynecologic Medical Oncology Service, Memorial Sloan Kettering Cancer Center, New York, USA.
  • Di Silvestro PA; Department of Obstetrics and Gynecology, Women & Infants Hospital, Providence, USA.
  • Jelovac D; Division of Medical Oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, USA.
  • Carter JS; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Virginia Commonwealth University, Richmond, USA.
  • Duan W; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University College of Medicine, Columbus, USA.
  • Resnick KE; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Case Western Reserve University School of Medicine, Cleveland, USA.
  • Dizon DS; Division of Medical Gynecologic Oncology, Massachusetts General Hospital Cancer Center, Boston, USA.
  • Aghajanian C; Department of Medicine, Gynecologic Medical Oncology Service, Memorial Sloan Kettering Cancer Center, New York, USA.
  • Fracasso PM; Division of Hematology/Oncology, Department of Medicine, University of Virginia, Charlottesville, USA.
Ann Oncol ; 28(3): 505-511, 2017 03 01.
Article em En | MEDLINE | ID: mdl-27998970
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Benzimidazóis / Carcinoma / Neoplasias do Colo do Útero / Recidiva Local de Neoplasia Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Benzimidazóis / Carcinoma / Neoplasias do Colo do Útero / Recidiva Local de Neoplasia Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article